Esophageal squamous-cell carcinoma (ESCC) is one of the most common malignancies in Asia.

The only factor predictive of pCR was squamous-cell carcinoma.

This drug could offer a potential new treatment approach for patients with treatment-refractory advanced squamous-cell carcinoma.

Purpose: This study was designed to evaluate one institution's experience with treatment outcomes for rectal squamous-cell carcinoma.

Adenocarcinoma developed from the columnar-lined epithelium near the esophago-jejunostoma, while adenosquamous and squamous-cell carcinoma arose from the squamous esophagitis.

Immunohistochemistry suggests a common cellular origin for rectal squamous-cell carcinoma and rectal adenocarcinoma, which is different from anal squamous-cell carcinoma.

The UM-SCV-1 cell lines express membrane antigens typically displayed by squamous-cell carcinomas.

Squamous-cell carcinoma arising in a pilonidal sinus is a rare occasion.